Bio-Rad Laboratories Company Profile (NYSE:BIO)

About Bio-Rad Laboratories

Bio-Rad Laboratories logoBio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company's Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company's Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: BIO
  • CUSIP: 09057220
Key Metrics:
  • Previous Close: $151.25
  • 50 Day Moving Average: $149.06
  • 200 Day Moving Average: $142.31
  • Trailing P/E Ratio: 45.88
  • Foreward P/E Ratio: 41.44
  • P/E Growth: 4.88
  • Market Cap: $4.45B
  • Outstanding Shares: 29,423,000
  • Beta: 0.96
Additional Links:
Companies Related to Bio-Rad Laboratories:

Analyst Ratings

Consensus Ratings for Bio-Rad Laboratories (NYSE:BIO) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $149.00 (1.49% downside)

Analysts' Ratings History for Bio-Rad Laboratories (NYSE:BIO)
Show:
DateFirmActionRatingPrice TargetDetails
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details
11/4/2015Leerink SwannBoost Price Target$143.00 -> $149.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Bio-Rad Laboratories (NYSE:BIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
8/3/2016Q2$1.13$0.61$497.80 million$516.80 millionViewN/AView Earnings Details
5/5/2016Q1$0.60$0.42$463.90 million$471.20 millionViewN/AView Earnings Details
2/25/2016Q415$1.27$1.68$570.80 million$570.56 millionViewListenView Earnings Details
11/3/2015Q315$0.54$0.59$495.55 million$469.96 millionViewN/AView Earnings Details
8/6/2015Q215$0.78$0.97$494.85 million$506.10 millionViewN/AView Earnings Details
5/5/2015Q115$0.33$0.61$474.60 million$472.80 millionViewN/AView Earnings Details
2/26/2015Q414$1.18$1.34$593.41 million$598.20 millionViewN/AView Earnings Details
11/4/2014Q314$0.86$0.39$525.40 million$530.64 millionViewN/AView Earnings Details
8/5/2014Q214$0.95$1.09$537.58 million$536.80 millionViewN/AView Earnings Details
5/6/2014Q114$0.80$0.23$515.00 million$509.30 millionViewN/AView Earnings Details
2/27/2014Q413$1.42$1.04$586.67 million$602.60 millionViewListenView Earnings Details
11/7/2013Q313$0.91($0.25)$529.02 million$505.10 millionViewListenView Earnings Details
8/6/2013Q2 2013$1.25$1.20$532.60 million$525.30 millionViewListenView Earnings Details
5/7/2013Q1 2013$1.03$0.68$506.34 million$499.70 millionViewN/AView Earnings Details
2/26/2013Q4 2012$1.33$1.65$558.68 million$573.80 millionViewN/AView Earnings Details
11/6/2012Q312$1.14$1.48$507.79 million$498.70 millionViewN/AView Earnings Details
8/7/2012$1.19$1.69ViewN/AView Earnings Details
5/1/2012$1.02$1.09ViewN/AView Earnings Details
2/23/2012$1.67$2.08ViewN/AView Earnings Details
11/1/2011$1.53$1.61ViewN/AView Earnings Details
8/2/2011$1.47$1.41ViewN/AView Earnings Details
5/3/2011$1.32$1.16ViewN/AView Earnings Details
2/24/2011$1.35$2.41ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bio-Rad Laboratories (NYSE:BIO)
Current Year EPS Consensus Estimate: $3.10 EPS
Next Year EPS Consensus Estimate: $3.65 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.72$0.85$0.79
Q2 20163$1.01$1.12$1.07
Q3 20162$0.51$0.84$0.68
Q4 20162$1.15$1.55$1.35
Q1 20171$0.78$0.78$0.78
Q2 20171$1.09$1.09$1.09
Q3 20171$0.79$0.79$0.79
Q4 20171$0.98$0.98$0.98
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Bio-Rad Laboratories (NYSE:BIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bio-Rad Laboratories (NYSE:BIO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Bio-Rad Laboratories (NYSE:BIO)
DateHeadline
sbwire.com logoTransplantation Diagnostics Market Is Expected to Reach $2,059.2 Million by 2022; Finds New Report (NYSE:BIO)
www.sbwire.com - August 29 at 4:27 PM
News IconEurope Molecular Diagnostics Market Worth $4.0 Billion By 2024: Grand View Research, Inc. (NYSE:BIO)
www.abnewswire.com - August 26 at 11:55 AM
einnews.com logoGlobal Transplantation Diagnostics Market 2016 Share, Trend, Segmentation and Forecast to 2022 (NYSE:BIO)
world.einnews.com - August 26 at 11:55 AM
einnews.com logoImmunoassay Global Market Segmentation,Application,Technology & Market Analysis Research Report 2022 (NYSE:BIO)
www.einnews.com - August 25 at 9:17 PM
News IconUrinalysis Test Market Regional Analysis, Market Share and Forecast to 2027. (NYSE:BIO)
www.medgadget.com - August 25 at 8:42 AM
finance.yahoo.com logoBiochip Market Size Projected to Reach $25.8 Billion by 2024: Grand View Research, Inc. (NYSE:BIO)
finance.yahoo.com - August 24 at 3:50 PM
einnews.com logoUrinalysis Test Market Development, Market Trend, Segmentation and Forecast to 2027. (NYSE:BIO)
world.einnews.com - August 24 at 3:50 PM
4-traders.com logoBio Rad Laboratories : Assigned Patent (NYSE:BIO)
www.4-traders.com - August 24 at 3:50 PM
prnewswire.com logoBecton Dickinson, Bio-Rad Laboratories Inc. and Abbott Laboratories Likely to Continue Their Dominance in The ... - PR Newswire (press release) (NYSE:BIO)
www.prnewswire.com - August 23 at 3:52 PM
News IconStock Trading Above Moving Averages: Bio-Rad Laboratories, Inc. (NYSE:BIO) - Post News (NYSE:BIO)
www.kentuckypostnews.com - August 23 at 5:13 AM
News IconLyme Disease Diagnostic Market Analysis Report 2015-2022 (NYSE:BIO)
reports.pr-inside.com - August 22 at 8:38 AM
4-traders.com logoBio Rad Laboratories : Combine Solicitation - Bio-Rad NGC Quest 10 (NYSE:BIO)
www.4-traders.com - August 22 at 8:38 AM
investornewswire.com logoWill Bio-Rad Laboratories, Inc. (NYSE:BIO) Hit $200 Price Target? - Investor Newswire (NYSE:BIO)
www.investornewswire.com - August 21 at 8:33 AM
News IconBrokerage Firm Targets in Focus for Bio-Rad Laboratories, Inc. (NYSE:BIO) - Post News (NYSE:BIO)
www.kentuckypostnews.com - August 20 at 8:51 AM
News IconShare Valuation Review for Bio-Rad Laboratories, Inc. (NYSE:BIO) - Post News (NYSE:BIO)
www.kentuckypostnews.com - August 20 at 8:51 AM
News IconShares Holding Above Moving Averages: Bio-Rad Laboratories, Inc. (NYSE:BIO) - Post News (NYSE:BIO)
www.kentuckypostnews.com - August 20 at 8:51 AM
News IconEurope IVD Market Projected To Reach $15.5 Billion By 2024: Grand View Research, Inc. (NYSE:BIO)
www.abnewswire.com - August 18 at 3:58 PM
News IconLatin America IVD Market Size To Reach $5.1 Billion By 2024: Grand View Research, Inc. (NYSE:BIO)
www.usfinancialnewstoday.com - August 17 at 3:56 PM
News IconGlobal Electrophoresis Market 2016: Industry Review, Statistics, and Growth to 2022 (NYSE:BIO)
qwtjlive.com - August 16 at 9:06 PM
fidaily.com logoAriel Investments, LLC Adjusts Its Holdings in Bio-Rad Laboratories, Inc. Clas (BIO) Last Quarter - Finance Daily (NYSE:BIO)
www.fidaily.com - August 15 at 11:03 AM
News IconReport explores the global food additives testing sales market forecast to 2021 (NYSE:BIO)
www.whatech.com - August 12 at 9:19 PM
News IconBiomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020 (NYSE:BIO)
www.pressreleaserocket.net - August 12 at 12:28 PM
News IconGlobal mitochondrial disorders genetic testing market forecast to 2021 available in new report (NYSE:BIO)
www.whatech.com - August 12 at 12:28 PM
finance.yahoo.com logoGlobal Market Study on Western Blotting: Increasing Prevalence of HIV and Spontaneous Research in the … (NYSE:BIO)
finance.yahoo.com - August 11 at 9:43 PM
finance.yahoo.com logoBIO RAD LABORATORIES INC Financials (NYSE:BIO)
finance.yahoo.com - August 11 at 3:54 PM
finance.yahoo.com logoLife Science Instrumentation Market Worth 64.52 Billion USD by 2021 (NYSE:BIO)
finance.yahoo.com - August 11 at 11:59 AM
sbwire.com logoAPAC Lateral Flow Diagnostic Tests Market Was Worth US $2.30 Bn in 2015 and Will Reach US $3.22 Bn by the End of 2023 (NYSE:BIO)
www.sbwire.com - August 10 at 9:17 PM
News IconBio-Rad Introduces an Assay Website to Identify or Design Droplet Digital™ PCR Assays (NYSE:BIO)
www.the-scientist.com - August 10 at 3:17 PM
finance.yahoo.com logoIllumina and FlowJo, LLC Partner to Develop and Co-Market a Software Solution for Single Cell Genomics (NYSE:BIO)
finance.yahoo.com - August 10 at 7:28 AM
News IconConsolidated Lateral Flow Diagnostic Tests Market in Asia Pacific will Reward Innovators, says TMR (NYSE:BIO)
www.medgadget.com - August 9 at 4:57 PM
capitalcube.com logoETF’s with exposure to Bio-Rad Laboratories, Inc. : August 9, 2016 (NYSE:BIO)
www.capitalcube.com - August 9 at 4:57 PM
News IconLATAM PoC Diagnostics Market Worth $1.73 Billion By 2024: Grand View Research, Inc. (NYSE:BIO)
www.econotimes.com - August 9 at 12:44 PM
capitalcube.com logoBio-Rad Laboratories, Inc. :BIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 (NYSE:BIO)
www.capitalcube.com - August 8 at 3:52 PM
investornewswire.com logoStrong Sell Calls For Bio-Rad Laboratories, Inc. (NYSE:BIO) At 0 - Investor Newswire (NYSE:BIO)
www.investornewswire.com - August 7 at 8:27 AM
biz.yahoo.com logoBIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly Report (NYSE:BIO)
biz.yahoo.com - August 5 at 9:14 PM
twst.com logoBio-Rad Laboratories Inc.: Bio-Rad Reports Second-Quarter 2016 Financial Results - The Wall Street Transcript (NYSE:BIO)
www.twst.com - August 4 at 12:26 PM
finance.yahoo.com logoEdited Transcript of BIO earnings conference call or presentation 3-Aug-16 9:00pm GMT (NYSE:BIO)
finance.yahoo.com - August 4 at 12:26 PM
twst.com logoBio-Rad Laboratories Inc.: Bio-Rad Reports Second-Quarter 2016 Financial Results (NYSE:BIO)
www.twst.com - August 3 at 9:31 PM
sg.finance.yahoo.com logoBio-Rad posts 2Q profit (NYSE:BIO)
sg.finance.yahoo.com - August 3 at 9:31 PM
publicnow.com logoBio-Rad Reports Second-Quarter 2016 Financial Results (NYSE:BIO)
www.publicnow.com - August 3 at 9:31 PM
sbwire.com logoMicrofluidics Market 2016: Global Industry Review, Research, Statistics, and Growth to 2021 (NYSE:BIO)
www.sbwire.com - August 3 at 12:30 PM
biz.yahoo.com logoQ2 2016 Bio Rad Laboratories Inc Earnings Release - After Market Close (NYSE:BIO)
biz.yahoo.com - August 3 at 12:30 PM
News IconNew report: Blood testing market 2016 global trends, market share, industry size, growth, opportunities, and market forecast to 2022 (NYSE:BIO)
www.whatech.com - August 2 at 9:30 PM
sbwire.com logoAutomated Molecular Diagnostics Testing System Market Expected to Expand at a Steady CAGR Through 2026 (NYSE:BIO)
www.sbwire.com - August 2 at 9:30 PM
bizjournals.com logoGlobal Market of Infectious Disease Diagnostics is Estimated to Reach US$ 1503.8 Mn by 2024 (NYSE:BIO)
www.bizjournals.com - August 2 at 8:39 AM
zacks.com logoMedical Product Stocks Earnings Preview for Aug 3: BIO, CSII & More (NYSE:BIO)
www.zacks.com - August 2 at 8:38 AM
einnews.com logoBlood Testing Market to Reach $60.59 billion with 2.35% CAGR Forecast to 2022 (NYSE:BIO)
world.einnews.com - August 1 at 3:49 PM
News IconFood diagnostics systems market size, analysis, report, trends, share, opportunities and forecast to 2022 available in new report (NYSE:BIO)
www.whatech.com - August 1 at 8:46 AM
News IconMultiplex Assays Market Worth 3.76 Billion USD by 2021 (NYSE:BIO)
www.medindia.net - August 1 at 8:46 AM
News IconBio-Rad expands product line by launching two human recombinant antigens (NYSE:BIO)
www.news-medical.net - August 1 at 8:46 AM

Social

Bio-Rad Laboratories (NYSE:BIO) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff